News & Views | Published:

Illuminating next-generation brain therapies

Nature Neuroscience volume 19, pages 414416 (2016) | Download Citation

A clinical trial inspired and guided by optogenetics experiments in rodents reports the outcome of targeted transcranial magnetic stimulation in patients suffering from cocaine addiction.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    Office of National Drug Control Policy. The Economic Costs of Drug Abuse in the United States, 1992–2002. Publication No. 207303 (Washington, DC: Executive Office of the President, 2004).

  2. 2.

    Nat. Neurosci. 18, 1213–1225 (2015).

  3. 3.

    et al. Cell 147, 678–689 (2011).

  4. 4.

    et al. Nature 477, 171–178 (2011).

  5. 5.

    et al. Proc. Natl. Acad. Sci. USA published online, (22 December 2015).

  6. 6.

    et al. Eur. Neuropsychopharmacol. published online, (20 November 2015).

  7. 7.

    et al. Nature 496, 359–362 (2013).

  8. 8.

    , & Curr. Opin. Psychiatry 26, 13–18 (2013).

  9. 9.

    et al. Science (1 January 2016).

  10. 10.

    Substance Abuse and Mental Health Services Administration. Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings, NSDUH Series H-48, HHS Publication No. (SMA) 14–4863 (Rockville, MD: Substance Abuse and Mental Health Services Administration, 2014).

  11. 11.

    , , , & Science 324, 354–359 (2009).

  12. 12.

    Nature 505, 309–317 (2014).

  13. 13.

    et al. Front. Hum. Neurosci. 6, 155 (2012).

  14. 14.

    et al. Biol. Psychiatry 76, 963–969 (2014).

  15. 15.

    , & Science 347, 659–664 (2015).

Download references

Author information

Affiliations

  1. Emily Ferenczi and Karl Deisseroth are in the Department of Bioengineering, Stanford University, Stanford, California, USA

    • Emily Ferenczi
    •  & Karl Deisseroth
  2. Karl Deisseroth is in the Howard Hughes Medical Institute and Department of Psychiatry & Behavioral Sciences, Stanford University, Stanford, California, USA.

    • Karl Deisseroth

Authors

  1. Search for Emily Ferenczi in:

  2. Search for Karl Deisseroth in:

Competing interests

K.D. is a consultant and shareholder of Circuit Therapeutics Inc., a start-up company building platforms for drug discovery and nervous system intervention with optogenetics.

Corresponding author

Correspondence to Karl Deisseroth.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nn.4232

Further reading

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing